Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for intravenous administration. It is commonly associated with clot-busting therapy and is manufactured by Boehringer Ingelheim Zagreb D.O.O.

Actilyse is primarily used to dissolve blood clots in conditions like stroke or heart attack. It works by breaking down fibrin, a protein involved in blood clot formation. This medication is often administered in emergency settings to restore blood flow and reduce damage. What is Actilyse used for? It is typically used for acute ischemic stroke and myocardial infarction.

Common effects of Actilyse may include bleeding at the injection site or other parts of the body. Patients might also experience bruising, low blood pressure, or allergic reactions. These effects can vary depending on individual health conditions and the specific use case.

Actilyse should be handled with care, as it can increase the risk of bleeding. It is important to inform healthcare providers about any history of bleeding disorders or recent surgeries. Proper monitoring is essential during and after administration to manage potential complications.

Actilyse may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is crucial to discuss all current medications with a healthcare provider to avoid adverse interactions. Alcohol and certain supplements might also influence its effectiveness.